Bleeding after open heart surgery is common and has two broad categories of causes: bleeding from the surgical sites themselves and bleeding caused by changes in how your blood clots. In about two-thirds of cases, surgeons can trace the bleeding back to a specific physical location in the chest. The remaining cases stem from a body-wide disruption in clotting ability, largely triggered by the heart-lung bypass machine used during the procedure.
Surgical Sites Where Bleeding Originates
A meta-analysis published in the Journal of Cardiothoracic and Vascular Anesthesia found that surgical sites accounted for 65.7% of post-cardiac surgery bleeding. The most common locations were the body of a bypass graft (20.2% of cases), the breastbone itself (17.0%), the area where the internal mammary artery was harvested for grafting (13.0%), vascular suture lines (12.5%), and the connections where grafts meet existing blood vessels (9.9%). About 41% of bleeding originated from cardiac structures, while 27% came from the breastbone and surrounding tissue in the chest cavity.
These numbers make sense when you consider how many incisions, connections, and raw tissue surfaces a single open heart procedure creates. A coronary artery bypass, for example, involves opening the chest, harvesting a blood vessel from elsewhere in the body, and sewing it onto the heart in multiple places. Each of those sites can ooze or bleed, especially in the first hours after surgery when blood pressure rises back to normal levels.
How the Heart-Lung Machine Disrupts Clotting
During open heart surgery, a cardiopulmonary bypass (CPB) machine temporarily takes over the work of the heart and lungs. Your blood leaves your body, passes through plastic tubing, a membrane oxygenator, and various connectors, then returns. That contact with artificial surfaces triggers a cascade of problems for your clotting system.
First, the circuits must be filled with fluid before surgery begins, which dilutes your blood. This hemodilution reduces the concentration of platelets and clotting proteins circulating in your bloodstream. Second, the foreign surfaces of the machine activate your body’s inflammatory response, which in turn triggers both the clotting system and the system that breaks clots down. The result is a kind of exhaustion: clotting factors get used up, platelets become less responsive to signals telling them to form clots, and the balance between clot formation and clot breakdown tips toward bleeding. Longer time on the bypass machine and lower body temperatures during surgery both make this worse.
Blood-Thinning Medications Before Surgery
Many people who need heart surgery are already taking medications that reduce their blood’s ability to clot. Aspirin and clopidogrel are the two most common. Both work by permanently disabling platelets, and since that effect lasts for the entire 7 to 9 day lifespan of each affected platelet, stopping these drugs just a day or two before surgery isn’t enough to restore normal clotting.
When surgery is urgent, there may not be time for a full washout period. In those situations, patients go into the operating room with a significant portion of their circulating platelets unable to function normally. This compounds the clotting problems already caused by the bypass machine and increases postoperative blood loss. Surgeons weigh the bleeding risk of continuing these medications against the clotting risk of stopping them, since the very conditions that led to surgery (blocked arteries, recent stent placement) make blood clots dangerous too.
Heparin and Its Reversal
Before connecting a patient to the bypass machine, the surgical team administers heparin, a powerful blood thinner that prevents clots from forming inside the circuit. Once the machine is no longer needed, a drug called protamine is given to neutralize the heparin. The standard approach is roughly 1 to 1.5 mg of protamine for every 100 units of heparin used.
This reversal isn’t always clean. Too little protamine leaves residual heparin activity, which keeps the blood thin. Too much protamine creates its own problems: it can impair platelet function, interfere with clotting factors, and even promote clot breakdown. In some patients, heparin effects can also “rebound” after protamine wears off, causing a second wave of impaired clotting hours after surgery seemed to go smoothly.
Patient Factors That Raise the Risk
Not everyone faces the same bleeding risk. Research from a large study of coronary artery bypass patients identified several factors that independently increased the chance of returning to the operating room for bleeding: older age (particularly over 75), smaller body size, longer time on the bypass machine, and a higher number of graft connections performed during surgery. Smaller patients have less blood volume to begin with, so even moderate bleeding represents a larger proportion of their total supply. Older patients tend to have more fragile blood vessels and less robust clotting responses.
When Bleeding Happens
The highest risk window is the first 24 hours. A large study published in JAMA Network Open found that 42.7% of all major bleeding events in the first 30 days after surgery occurred on the first postoperative day. By 48 hours, more than half of all major bleeding episodes had already happened. By the end of the first week, 77.7% had occurred. Bleeding after the first two weeks is uncommon, with 88.3% of events resolved by day 14.
This is why patients spend the first day or two in the intensive care unit with chest tubes draining fluid and blood from the surgical area. The care team monitors the output closely. Drainage exceeding 200 mL in a single hour, or more than 2 mL per kilogram of body weight per hour for two consecutive hours during the first six hours, signals a serious problem. A study of cardiac surgery patients found that exceeding these thresholds was associated with a 2.9 times higher risk of death within 30 days, a 3.3 times higher risk of stroke, and dramatically higher odds of needing a return trip to the operating room.
What Happens When Bleeding Is Severe
When bleeding doesn’t stop on its own or with medications, the surgical team has two main paths. For clotting-related bleeding, they can give blood products: red blood cells to replace what’s lost, plasma to replenish clotting proteins, and platelet transfusions to restore clotting ability. Research shows that giving these in balanced ratios (roughly equal amounts of plasma, platelets, and red blood cells) leads to better outcomes than giving red blood cells alone. In a landmark trial, patients who received a 1:1:1 ratio of plasma to platelets to red blood cells achieved hemostasis 86% of the time, compared to 78% with less balanced ratios.
Medications that slow the breakdown of blood clots are also commonly used during and after surgery. These drugs work by blocking the conversion of an inactive protein in your blood into its active, clot-dissolving form. They’re particularly useful in patients who are known to be at higher risk, such as elderly patients, those with small body frames, or anyone facing a long time on the bypass machine.
When the bleeding source is surgical rather than a clotting problem, the patient may need re-exploration. This means returning to the operating room so the surgeon can reopen the chest, identify the specific site that’s bleeding, and repair it directly. While this sounds alarming, it’s a well-established part of cardiac surgery care and is sometimes the fastest path to stopping blood loss that medications and transfusions can’t control.
Cardiac Tamponade: A Dangerous Complication
One particularly serious form of postoperative bleeding is cardiac tamponade, where blood collects in the sac surrounding the heart and compresses it, preventing it from filling properly. Warning signs include a rapid heart rate, falling blood pressure, muffled or distant heart sounds, and visibly swollen neck veins. Paradoxically, chest tube output may actually decrease during tamponade because the blood is collecting in a space the tubes aren’t draining effectively, or because clots are blocking the tubes.
Tamponade is a surgical emergency. The pressure on the heart can quickly become life-threatening if the accumulated blood isn’t drained. This is one reason the ICU team watches not just for high chest tube output but also for the combination of low output with signs of cardiovascular decline.